Ohio State University College of Dentistry

CalciMedica Announces Upcoming Presentations and Events in September

Retrieved on: 
Wednesday, September 6, 2023

LA JOLLA, Calif., Sept. 6, 2023 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a presentation at the H.C. Wainwright 25th Annual Global Investment Conference on Wednesday, September 13, 2023, at 1:30 p.m. – 2:00 p.m. ET/ 10:30 a.m. – 11 a.m. PT.

Key Points: 
  • LA JOLLA, Calif., Sept. 6, 2023 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a presentation at the H.C. Wainwright 25th Annual Global Investment Conference on Wednesday, September 13, 2023, at 1:30 p.m. – 2:00 p.m. ET/ 10:30 a.m. – 11 a.m. PT.
  • The Company will also be hosting a virtual Acute Pancreatitis Clinical Experts Event on Thursday, September 21, 2023, from 10:30 a.m. – 12 p.m. ET/ 7:30 a.m. – 9 a.m. PT featuring Joseph Miller, M.D., Clinical Associate Professor of Emergency Medicine at Henry Ford Health and Michigan State University and Associate Director of Emergency Care Research at Henry Ford Health, and Georgios Papachristou, M.D., Ph.D., Professor of Medicine, Floyd Beman Endowed Chair in Gastroenterology and division director for Gastroenterology, Hepatology and Nutrition at The Ohio State University College of Medicine.
  • Live webcasts of both events, as well as registration for the clinical experts event, can be accessed in the "Upcoming Events" section of CalciMedica's IR website at https://ir.calcimedica.com/ .
  • A replay of the Acute Pancreatitis Clinical Experts Event will be available for one year following the completion of the event, and a replay of the conference presentation will be available for 90 days.

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

Retrieved on: 
Thursday, August 31, 2023

LA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a virtual clinical experts event on Thursday, September 21, 2023, from 10:30 a.m. – 12 p.m. ET/ 7:30 a.m. – 9 a.m. PT.

Key Points: 
  • LA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a virtual clinical experts event on Thursday, September 21, 2023, from 10:30 a.m. – 12 p.m. ET/ 7:30 a.m. – 9 a.m. PT.
  • CalciMedica management will be joined by clinical experts Joseph Miller, M.D., clinical associate professor of Emergency Medicine at Henry Ford Health and Michigan State University and associate director of Emergency Care Research at Henry Ford Health, and Georgios Papachristou, M.D., Ph.D., professor of Medicine, Floyd Beman Endowed Chair in Gastroenterology and division director for Gastroenterology, Hepatology and Nutrition at The Ohio State University College of Medicine in discussing the Company's lead clinical compound, Auxora™, and its potential implications in acute pancreatitis.
  • Registration for the event will be available in the "Upcoming Events" section of CalciMedica's IR website at https://ir.calcimedica.com/ beginning at 7:30 a.m.
  • ET on Wednesday, September 6.

Phil Wenk to Retire as CEO of Delta Dental of Tennessee and become President of the Company’s Charitable Foundation; Jeff Ballard Named Successor

Retrieved on: 
Tuesday, August 29, 2023

Delta Dental of Tennessee (Delta Dental) today announced that Dr. Phil Wenk will retire as chief executive officer (CEO) on December 31, 2023.

Key Points: 
  • Delta Dental of Tennessee (Delta Dental) today announced that Dr. Phil Wenk will retire as chief executive officer (CEO) on December 31, 2023.
  • Jeff Ballard, CPA, current president and CFO of Delta Dental, will succeed Wenk and become president and CEO effective January 1, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20230829965953/en/
    Jeff Ballard (left), president and CFO of Delta Dental, will succeed Dr. Phil Wenk (right) and become president and CEO effective January 1, 2024.
  • (Photo: Business Wire)
    Dr. Wenk joined Delta Dental in 1997 after practicing dentistry for 20 years and has led the company as President and CEO since 2000.

The Inner Circle Acknowledges, Nancy J. Keogh as a Most Trusted Healthcare Professional for her contributions to the field of Psychology.

Retrieved on: 
Tuesday, July 11, 2023

CUYAHOGA FALLS, Ohio, July 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Nancy J. Keogh is acknowledged as a Most Trusted Healthcare Professional for her contributions to the field of Psychology.

Key Points: 
  • CUYAHOGA FALLS, Ohio, July 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Nancy J. Keogh is acknowledged as a Most Trusted Healthcare Professional for her contributions to the field of Psychology.
  • Dr. Keogh pursued higher education at University of Ohio Miami where she earned a Bachelor's degree.
  • She then attended the University of Akron and earned both a Masters and a PhD in Psychology in 1983.
  • Dr. Keogh was also the clinical director of the Community Health Center in Akron Ohio from 1996 to 2018.

Merck Manuals Shares Keys to Curbing Halitosis

Retrieved on: 
Thursday, June 15, 2023

RAHWAY, N.J., June 15, 2023 /PRNewswire/ -- Halitosis – more commonly known as bad breath – can have serious social consequences. But in a new editorial from MerckManuals.com, one expert points out that halitosis may also be a sign of other, underlying medical conditions.

Key Points: 
  • RAHWAY, N.J., June 15, 2023 /PRNewswire/ -- Halitosis – more commonly known as bad breath – can have serious social consequences.
  • But in a new editorial from MerckManuals.com , one expert points out that halitosis may also be a sign of other, underlying medical conditions.
  • Bernard J. Hennessy, DDS, Texas A&M University, College of Dentistry, shares his steps for identifying the cause of halitosis as well as treating and eliminating it.
  • Bad breath is most often caused by the action of certain mouth bacteria, Hennessy explains.

Rebecca Atwood DVM Joins Petland as Director of Veterinary Operations

Retrieved on: 
Wednesday, April 5, 2023

CHILLICOTHE, Ohio, April 5, 2023 /PRNewswire/ -- Petland, Inc. is pleased to welcome Rebecca Atwood, DVM as Director of Veterinary Operations.

Key Points: 
  • CHILLICOTHE, Ohio, April 5, 2023 /PRNewswire/ -- Petland, Inc. is pleased to welcome Rebecca Atwood, DVM as Director of Veterinary Operations.
  • She will also develop, deliver, and sustain a comprehensive animal husbandry and veterinary health care prevention and welfare program for Petland's company store locations.
  • Dr. Atwood will be a consistent resource for consulting veterinarians in meeting Petland best practices and protocols.
  • Along with leading the care of pets within Petland operations, Dr. Atwood will provide veterinary oversight of every step of a pet's journey, making science-based recommendations to optimize each pets' health.

IOF Research Grants Aim to Enhance Clinical Transformation: Reviews Completed

Retrieved on: 
Monday, March 27, 2023

The first IOF Research Grants Program Review Committee consisted of 12 prominent professors who served as reviewers from all over the world.

Key Points: 
  • The first IOF Research Grants Program Review Committee consisted of 12 prominent professors who served as reviewers from all over the world.
  • “Orthodontic research has had fewer funding channels available for basic and clinical research over the years.
  • This year, funded grant awardees will study clinical, basic science and translational research.” explained Prof. Ravindra Nanda, editor-in-chief at Progress in Orthodontics.
  • In his view, the most distinctive trait of IOF Research Grants is its globalization.

Voltaren Teams Up with Actress Jennie Garth to Support Caregivers Nationwide

Retrieved on: 
Wednesday, May 4, 2022

WARREN, N.J., May 4, 2022 /PRNewswire/ -- 1 in 5 Americans provide care to family members or loved ones,1 a task that's inherently connected with physical pain. With many caregivers also dealing with the added challenges of experiencing joint pain, GSK Consumer Healthcare (LSE/NYSE: GSK) today announced Voltaren Arthritis Pain Gel is partnering with actress and caregiver Jennie Garth for the launch of CareWalks, an initiative dedicated to those who care for others.

Key Points: 
  • Data shows 94% of caregivers nationwide report musculoskeletal pain, 76% report lower back, knee and shoulder pain and 43% report wrist pain.
  • As part of CareWalks, Voltaren has teamed up with Jennie Garth, who was recently diagnosed with osteoarthritis and who served as the primary caregiver to her father before his passing.
  • Jennie, a Voltaren user herself, stars in the CareWalks video series, speaking with other real-life caregivers with joint pain about their shared experiences and challenges, to help raise awareness for this community nationwide.
  • "When I heard Voltaren was supporting caregivers, I knew I wanted to be involved," Jennie said.

Crest® Launches Year Two of “12 Days of Crest Smiles” to Grant Holiday Wishes to Those in Need

Retrieved on: 
Friday, December 17, 2021

Crest - the #1 Toothpaste brand in America - is excited to celebrate another year of its 12 Days of Crest Smiles holiday initiative.

Key Points: 
  • Crest - the #1 Toothpaste brand in America - is excited to celebrate another year of its 12 Days of Crest Smiles holiday initiative.
  • At the end of another unprecedented year, Crest is excited to grant 12 unforgettable Smile Wishes to children, families, and organizations for this holiday season.
  • The Crest holiday celebrations kicked off on December 9th and will joyfully share 12 smile wishes on social platforms Instagram and Twitter throughout December.
  • We are thrilled to celebrate the second year of 12 Days of Crest Smiles this holiday season and grant these special Smile Wishes to Ayden and so many others.

RadSite Announces Complimentary Fall Webinar Series Featuring Imaging Trends, Reimbursement Strategies and Leadership Opportunities

Retrieved on: 
Wednesday, September 22, 2021

ANNAPOLIS, Md., Sept. 22, 2021 /PRNewswire-PRWeb/ -- RadSite, a leading accreditation organization promoting quality-based imaging practices, announced today its fall webinar series on updates to key accreditation standards.

Key Points: 
  • ANNAPOLIS, Md., Sept. 22, 2021 /PRNewswire-PRWeb/ -- RadSite, a leading accreditation organization promoting quality-based imaging practices, announced today its fall webinar series on updates to key accreditation standards.
  • Starting on October 26, the monthly webinars address recent imaging trends covering RadSite Standards, reimbursement strategies, and leadership opportunities.
  • This webinar will feature an overview and updates to RadSite's MIPPA Accreditation Program Standards and Guide, including the new specialty accreditation modules.
  • The webinar will feature David J Waldron, CEO, Traction Business Development LLC, and Mark Casner, RadSite Accreditation Committee Chair.